SAGE Therapeutics Inc (SAGE.OQ) Key Developments | Reuters.com
Edition:
United States

Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

SAGE Therapeutics announces closing of initial public offering


Wednesday, 23 Jul 2014 06:30am EDT 

SAGE Therapeutics Inc:Closes its initial public offering of 5,750,000 shares of its common stock at a public offering price of $18.00 per share, before underwriting discounts.Company's common stock is listed on The NASDAQ Global Market under the symbol "SAGE.".J.P. Morgan Securities LLC and Goldman, Sachs & Co. acted as joint book-running managers for the offering.Leerink Partners LLC acted as lead manager and Canaccord Genuity Inc. acted as co-manager. 

Company Quote

30.13
 --
30 Jun 2016